Your browser doesn't support javascript.
loading
Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease.
Muntner, Paul; Orroth, Kate K; Mues, Katherine E; Exter, Jason; Shannon, Erin D; Zaha, Rebecca; Rosenson, Robert S; Jackson, Elizabeth A.
Afiliación
  • Muntner P; Department of Epidemiology, University of Alabama at Birmingham, 1720 2nd Ave South, RPHB 140J, Birmingham, AL, 35294-0013, USA. pmuntner@uab.edu.
  • Orroth KK; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA.
  • Mues KE; Amgen Inc., Thousand Oaks, CA, USA.
  • Exter J; Amgen Inc., Thousand Oaks, CA, USA.
  • Shannon ED; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA.
  • Zaha R; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA.
  • Rosenson RS; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Jackson EA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Cardiovasc Drugs Ther ; 36(3): 475-481, 2022 06.
Article en En | MEDLINE | ID: mdl-33661432
PURPOSE: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline defines very high atherosclerotic cardiovascular disease (ASCVD) risk as a history of ≥ 2 major ASCVD events or 1 major ASCVD event and multiple high-risk conditions. We tested if a simplified approach, having a history of a major ASCVD event, would identify a high proportion of patients that meet the 2018 AHA/ACC cholesterol guideline criteria for very high risk. METHODS: We analyzed data from US adults with health insurance in the MarketScan database who had experienced an acute coronary syndrome in the past year (recent ACS, n = 3626), a myocardial infarction (MI) other than a recent ACS (n = 7572), an ischemic stroke (n = 3551), or symptomatic peripheral artery disease (PAD, n = 5919). Patients were followed from January 1, 2016, through December 31, 2017, for recurrent ASCVD events. RESULTS: Among 16,344 patients with a history of a major ASCVD event, 94.0% met the 2018 AHA/ACC cholesterol guideline definition for very high risk including 92.9%, 96.5%, 93.1%, and 96.2% with a recent ACS, history of MI, history of stroke, and symptomatic PAD, respectively. The incidence of ASCVD events per 1000 person-years was 50.4 (95% CI: 47.6-53.3) among all patients with a history of a major ASCVD event versus 53.1 (95% CI: 50.1-56.1) among patients who met the 2018 AHA/ACC cholesterol guideline definition of very high risk. CONCLUSION: The vast majority of patients with a recent ACS, history of MI, ischemic stroke, or symptomatic PAD meet the 2018 AHA/ACC cholesterol guideline definition of very high risk.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cardiología / Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis / Accidente Cerebrovascular Isquémico Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Cardiovasc Drugs Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cardiología / Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis / Accidente Cerebrovascular Isquémico Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Cardiovasc Drugs Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos